Featured
Peer-Reviewed Publication: Integrative Framework for Thyroid & Endocrine Resilience
Ashwagandha-Free Adaptogens: Stress Support for Sensitive Individuals*
For individuals whose systems are already highly vigilant or reactive, certain adaptogens may feel mismatched, even if they are broadly beneficial in other populations. Several well-studied adaptogenic botanicals offer stress-buffering support without the same profile that can feel activating or suppressive for ashwagandha-sensitive individuals.*
Read now
Hypothyroidism and Depression: Why They’re So Often Confused
The overlap between hypothyroidism and depression is not a coincidence. It reflects shared physiology, shared neuroendocrine pathways, and a long history of clinical observation that continues to be supported by modern research. Understanding this overlap requires moving beyond symptom checklists and into the biology of how thyroid hormones interact with the brain.
Read now
Beyond the Uterus: Why Progesterone Still Matters After Hysterectomy
The idea that women without a uterus don’t need progesterone is misleading. While progesterone is no longer required to protect the endometrium after hysterectomy, it still plays important systemic roles throughout the body. Progesterone receptors exist in the brain, bones, breasts, blood vessels, and immune cells, meaning it can influence mood, anxiety, sleep quality, cognition, bone formation, breast comfort, inflammation, and metabolic and cardiovascular function. Data shows the therapeutic use of bioidentical progesterone in the right context, though it is not a cure-all and must be paired with healthy lifestyle choices.
Read now
Estrogen: No Black Box Warning—Now What?
For more than two decades, fear stemming from early, oversimplified interpretations of the Women’s Health Initiative led many women and clinicians to avoid hormone replacement therapy, culminating in a black box warning on estrogen. In 2025, the FDA removed that warning for estrogen-only therapies, reflecting clearer evidence that risks depend heavily on age, timing, hormone type, and route of administration—not the universal danger once assumed. Updated research shows that starting hormone therapy within ten years of menopause, using bioidentical formulations, and choosing non-oral routes can significantly reduce risks, while estrogen-only therapy has not been shown to raise breast cancer risk. The label change does not mean hormone therapy is risk-free, but it does open the door to individualized, evidence-based decision-making. With better data and more nuance, women and clinicians can move forward with informed conversations rather than fear-driven avoidance.
Read now
Spearmint Benefits: What Every Clinician Should Know
Explore key insights on spearmint benefits including support for cognitive health, antioxidant activity, hormonal balance, and physical performance.*
Read now
Understanding the “MTHFR Gene Mutation C677T”: How It Affects You and How L-Methylfolate Can Help
If you’ve recently learned that you have the MTHFR gene mutation C677T, you might feel confused or unsure about what this means for your health. This article will break it down in simple terms, explaining why folate metabolism matters, what challenges this mutation presents, and how MethylPro®'s L-methylfolate supplements can support your health.
Read now
